A recent analysis reveals that ellipsoidal zone-retinal pigment epithelial thickness predicts future visual loss in ...

At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, the Eye Care Network caught up with Jogin ...

Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic ...

The study aims to identify the optimal dose of BI 1584862 and observe its impact on improving GA patients' eyes.

Hamby and Lizama, shows zervimesine may protect retinal cells from the onslaught ... concept clinical trial in 100 people with geographic atrophy secondary to dry AMD, treatment with zervimesine ...

Cognition Therapeutics has announced positive topline outcomes from the Phase II MAGNIFY trial of zervimesine in adult ...

– Kriya is developing KRIYA-825 as a potential one-time gene therapy, delivered by suprachoroidal injection, expressing a fusion protein inhibiting the activity of complement C3 and C5 for the ...

As AMD progresses, the loss of retinal cells and the underlying blood vessels in the macula results in marked thinning and/or atrophy of retinal tissue. Geographic atrophy, associated with AMD ...